Drug Type T-lymphocyte cell therapy |
Synonyms- |
Target- |
Action- |
Mechanism T lymphocyte replacements |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acute Lymphoblastic Leukemia | Phase 1 | United States | 08 Feb 2008 | |
Acute Monocytic Leukemia | Phase 1 | United States | 08 Feb 2008 | |
Acute Myeloid Leukemia | Phase 1 | United States | 08 Feb 2008 | |
Blast Phase Chronic Granulocytic Leukemia | Phase 1 | United States | 08 Feb 2008 | |
Chronic phase chronic myeloid leukemia | Phase 1 | United States | 08 Feb 2008 | |
Myelodysplastic Syndromes | Phase 1 | United States | 08 Feb 2008 | |
Wilms Tumor | Phase 1 | United States | 08 Feb 2008 |